305 results on '"Ara, Takahide"'
Search Results
52. 造血幹細胞移植における腸内細菌叢の重要性
53. Effect of the COVID-19 pandemic on allogeneic stem cell transplantation in Japan
54. Risk factors for fatal cardiac complications after allogeneic hematopoietic cell transplantation: Japanese Society for Transplantation and Cellular Therapy transplant complications working group
55. Severe short-term adverse events in related bone marrow or peripheral blood stem cell donors
56. Calcineurin Inhibitors Inhibit Tolerance Induction By Suppressing Terminal Differentiation of Donor Exhausted T Cells after Allogeneic SCT
57. Intercellular Mitochondrial Transfer Enhances Metabolic Fitness and Anti-Tumor Effects of CAR T Cells
58. Donor Selection Considering Donor Age in Hematopoietic Cell Transplant Recipients 50-75 Years of Age
59. Reduced-Intensity Conditioning with Fludarabine/Busulfan Versus Fludarabine/Low-Dose Melphalan in Patients with Non-Hodgkin Lymphoma Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
60. Risk factors for fatal cardiac complications after allogeneic hematopoietic cell transplantation: Japanese Society for Transplantation and Cellular Therapy transplant complications working group.
61. Intestinal Lymphatic Endothelial Cells Produce R-Spondin3
62. The preceding hyponatremia is a useful hallmark for the diagnosis of HHV-6 encephalitis after allogeneic hematopoietic stem cell transplantation
63. Haploidentical transplantation with post‐transplant cyclophosphamide versus single cord blood transplantation for myelodysplastic syndrome: A retrospective study from the Adult Myelodysplastic Syndrome Working Group of the Japanese Society for Transplantation and Cellular Therapy ( JSTCT )
64. Antiretroviral therapy achieved metabolic complete remission of hepatic AIDS related Epstein-Barr virus-associated smooth muscle tumor
65. The preceding hyponatremia is a useful hallmark for the diagnosis of HHV-6 encephalitis after allogeneic hematopoietic stem cell transplantation
66. Prognostic impact of complex and/or monosomal karyotypes in post‐transplant poor cytogenetic acute myeloid leukaemia: A quantitative approach.
67. Adult patients with Ph+ ALL benefit from conditioning regimen of medium‐dose VP16 plus CY/TBI
68. Adult patients with Ph+ ALL benefit from conditioning regimen of medium‐dose VP16 plus CY/TBI
69. Antiretroviral therapy achieved metabolic complete remission of hepatic AIDS related Epstein-Barr virus-associated smooth muscle tumor
70. Registry data analysis of hematopoietic stem cell transplantation on systemic chronic active Epstein–Barr virus infection patients in Japan
71. Impact of HLA Epitope Matching on Outcomes After Unrelated Bone Marrow Transplantation
72. Loss of Y-Chromosome before Allogeneic Hematopoietic Stem Cell Transplantation Influences on Relapse in Male Recipients with Female Donors
73. Intensified conditioning regimens improved disease‐free survival and engraftment after unrelated single‐unit cord blood transplantation but not after matched sibling or matched unrelated donor allogeneic hematopoietic cell transplantation.
74. Improvements in Allogeneic Hematopoietic Cell Transplantation Outcomes for Adults With ALL Over the Past Three Decades: A Nationwide Registry Analysis From the Adult ALL WG of the JSTCT
75. New insight into pathophysiology and treatment of GVHD
76. Peritransplant glucocorticoids redistribute donor T cells to the bone marrow and prevent relapse after haploidentical SCT
77. Gvhd Targets Organoid-Forming Biliary Epithelial Stem Cells Via a TGF-β-Dependent Manner
78. The Outcomes of Systemic Chronic Active EBV Infection Treatment By Allogeneic Hematopoietic Stem Cell Transplantation: An Analysis of Japanese Registry Data
79. Letermovir Is Effective for Prevention of Cytomegalovirus Reactivation in HLA-Haploidentical Peripheral Blood Stem Cell Transplantation with Post-Transplant Cyclophosphamide
80. P1261: NEGATIVE IMPACT OF HLA‐B LEADER MISMATCH ON OUTCOMES OF HCT WITH PTCY FOR LYMPHOID MALIGNANCIES: A RETROSPECTIVE ANALYSIS FROM THE JAPANESE SOCIETY FOR TRANSPLANTATION AND CELLULAR THERAPY.
81. Novel Insights Into the Mechanism of GVHD-Induced Tissue Damage
82. Low-Dose ATG Has the Same Risk of CMV Reactivation after Allogeneic PBSCT As Ptcy, but Letemovir Is Effective in Preventing CMV Reactivation
83. Ferroptosis Inhibition Generates TCF-1 + CAR-T Cells with Enhanced Persistence and Cytotoxicity
84. Delayed Initiation of Calcineurin Inhibitor Is Critical for Tolerance Induction By Posttransplant Cyclophosphamide
85. Impact of Letermovir Prophylaxis for Cytomegalovirus Reactivation on Post-Transplant Outcomes 100 Days before and after Allogeneic Hematopoietic Cell Transplantation
86. The new generation tyrosine kinase inhibitor improves the survival of chronic myeloid leukemia patients after allogeneic stem cell transplantation.
87. High lymphocyte counts before antithymocyte globulin administration predict acute graft-versus-host disease
88. Chronic Diarrhea as the Presenting Feature of Amyloidosis with Multiple Myeloma: A Case Report Diagnosed by a Myocardial Biopsy
89. High lymphocyte counts before antithymocyte globulin administration predict acute graft-versus-host disease
90. Intestinal goblet cells protect against GVHD after allogeneic stem cell transplantation via Lypd8
91. Characterization of myeloid neoplasms following allogeneic hematopoietic cell transplantation.
92. 36 - Loss of Y-Chromosome before Allogeneic Hematopoietic Stem Cell Transplantation Influences on Relapse in Male Recipients with Female Donors
93. Short-term KRP203 and posttransplant cyclophosphamide for graft-versus-host disease prophylaxis
94. Reduced dose of MTX for GVHD prophylaxis promotes engraftment and decreases non-relapse mortality in umbilical cord blood transplantation.
95. Intestinal Goblet Cells Play a Protective Role Against GVHD Via a Lypd8-Dependent Manner after Allogeneic Hematopoietic Stem Cell Transplantation
96. Disseminated fusariosis emerged from prolonged local genital infection after cord blood transplantation
97. Degree of Intestinal Goblet-Cell Loss is Associated with Severity of Gvhd and Transplant Outcome, and Goblet Cell Growth Factor IL-25 Mitigates Gvhd
98. Graft-Versus-Host Disease Targets R-Spondin3-Producing Lymphatic Endothelial Cells in the Small Intestine
99. P1306: IMPACT OF HLA DISPARITY ON THE RISK OF OVERALL MORTALITY IN PATIENTS WITH EXTENSIVE CHRONIC GVHD.
100. R-Spondin1 expands Paneth cells and prevents dysbiosis induced by graft-versus-host disease
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.